Preliminary analysis of a single-center study on chidamide combined with ICD regimen in bortezomib-exposed relapsed/refractory multiple myeloma patients
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Zhenshu Xu, Ping Weng, Shujuan Xu, Xinxin Liu, Yanqin Cao, Bihong Cai, Guangyao Guo, Zezhong Yu, Qiaoqiao Song, Huijian Zheng, Nainong Li
Institutions: Fujian Medical University, Union Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417016768
Cites:
Cited by:
Related to: